Preconditioning-activated AKT controls neuronal tolerance to ischemia through the MDM2-p53 pathway

EN][One of the most important mechanisms of preconditioning-mediated neuroprotection is the attenuation of cell apoptosis, inducing brain tolerance after a subsequent injurious ischemia. In this context, the antiapoptotic PI3K/AKT signaling pathway plays a key role by regulating cell differentiation...

ver descrição completa

Detalhes bibliográficos
Autores: Barrio, Emilia, Vecino Pérez, Rebeca, Sánchez Morán, Irene, Rodríguez González, Cristina, Suárez Pindado, Alberto, Bolaños Hernández, Juan Pedro, Almeida Parra, María Ángeles, Delgado Esteban, María
Tipo de documento: artigo
Estado:Versão publicada
Data de publicação:2021
País:España
Recursos:Universidad de Salamanca (USAL)
Repositório:GREDOS. Repositorio Institucional de la Universidad de Salamanca
OAI Identifier:oai:gredos.usal.es:10366/155253
Acesso em linha:http://hdl.handle.net/10366/155253
Access Level:Acceso aberto
Palavra-chave:AKT
MDM2
p53
PI3K
Ischemic tolerance
Preconditioning
Proto-Oncogene Proteins c-mdm2
Ischemic Preconditioning
HEK293 Cells
Humans
Ischemia
Neurons
Apoptosis
Phosphorylation
Animals
Proto-Oncogene Proteins c-akt
Tumor Suppressor Protein p53
Signal Transduction
Phosphatidylinositol 3-Kinases
Mice
transducción de señales
apoptosis
humanos
ratones
neuronas
fosfatidil inositol 3 cinasas
proteína supresora de tumor p53
animales
proteínas protooncogénicas c-mdm2
isquemia
células HEK293
preacondicionamiento isquémico
fosforilación
proteínas protooncogénicas c-akt
Descrição
Resumo:EN][One of the most important mechanisms of preconditioning-mediated neuroprotection is the attenuation of cell apoptosis, inducing brain tolerance after a subsequent injurious ischemia. In this context, the antiapoptotic PI3K/AKT signaling pathway plays a key role by regulating cell differentiation and survival. Active AKT is known to increase the expression of murine double minute-2 (MDM2), an E3-ubiquitin ligase that destabilizes p53 to promote the survival of cancer cells. In neurons, we recently showed that the MDM2-p53 interaction is potentiated by pharmacological preconditioning, based on subtoxic stimulation of NMDA glutamate receptor, which prevents ischemia-induced neuronal apoptosis. However, whether this mechanism contributes to the neuronal tolerance during ischemic preconditioning (IPC) is unknown. Here, we show that IPC induced PI3K-mediated phosphorylation of AKT at Ser473, which in turn phosphorylated MDM2 at Ser166. This phosphorylation triggered the nuclear stabilization of MDM2, leading to p53 destabilization, thus preventing neuronal apoptosis upon an ischemic insult. Inhibition of the PI3K/AKT pathway with wortmannin or by AKT silencing induced the accumulation of cytosolic MDM2, abrogating IPC-induced neuroprotection. Thus, IPC enhances the activation of PI3K/AKT signaling pathway and promotes neuronal tolerance by controlling the MDM2-p53 interaction. Our findings provide a new mechanistic pathway involved in IPC-induced neuroprotection via modulation of AKT signaling, suggesting that AKT is a potential therapeutic target against ischemic injury.